Most Common Side Effects of Adalimumab
Adalimumab (Humira), a TNF blocker used for rheumatoid arthritis, psoriasis, Crohn's disease, and other autoimmune conditions, commonly causes injection-site reactions, infections, and headaches. These occur in more than 10% of patients in clinical trials.[1][2]
Patients most often report:
- Injection-site pain, redness, itching, or swelling (up to 20% of users).
- Upper respiratory tract infections (17%).
- Headaches (12%).
- Sinusitis (11%).
- Nausea (9%).
- Rash (6-7%).[1][3]
How Often Do Serious Side Effects Happen?
Serious issues like tuberculosis reactivation, serious infections (e.g., pneumonia), or malignancies affect 1-5% of patients, often in those with risk factors like age over 65 or diabetes. The FDA black box warns of these risks, with rates of serious infections around 4% per year.[2][4]
Why Do Injection-Site Reactions Occur?
These stem from the subcutaneous injection method. Rotating sites and using room-temperature drug reduces them. Most resolve within days without treatment.[1][3]
Side Effects in Specific Conditions
In rheumatoid arthritis trials, infections topped the list at 39% (vs. 30% placebo). Psoriasis patients saw more headaches and serum sickness-like reactions. Pediatric Crohn's users had higher rash rates.[2][5]
What Happens If You Get an Infection While on Adalimumab?
Stop the drug and contact your doctor immediately—risk of sepsis or fungal infections rises. Prophylactic screening for TB and hepatitis is standard before starting.[4]
Managing Common Side Effects
Over-the-counter pain relievers help headaches and site reactions. Monitor for fever or persistent symptoms. Lower doses or switching to biosimilars like adalimumab-abbv may reduce issues in some cases.[3][6]
Differences Between Brands and Biosimilars
Humira originator has similar profiles to biosimilars (e.g., Amjevita, Cyltezo), but some report fewer injection reactions with citrate-free versions. No major safety differences in trials.[6]
[1]: Humira Prescribing Information (FDA)
[2]: Drugs.com - Adalimumab Side Effects
[3]: Mayo Clinic - Adalimumab
[4]: FDA MedWatch - TNF Blockers
[5]: ClinicalTrials.gov - Humira Studies
[6]: DrugPatentWatch.com - Adalimumab Patents and Biosimilars